These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19324996)

  • 1. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene.
    Eriksson M; Schönland S; Yumlu S; Hegenbart U; von Hutten H; Gioeva Z; Lohse P; Büttner J; Schmidt H; Röcken C
    J Mol Diagn; 2009 May; 11(3):257-62. PubMed ID: 19324996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options.
    Moutafi M; Ziogas DC; Michopoulos S; Bagratuni T; Vasileiou V; Verga L; Merlini G; Palladini G; Matsouka C; Dimopoulos MA; Kastritis E
    BMC Med Genet; 2019 Jan; 20(1):23. PubMed ID: 30665372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity?
    Gaglione R; Smaldone G; Di Girolamo R; Piccoli R; Pedone E; Arciello A
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):377-384. PubMed ID: 29174954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary adrenal insufficiency due to hereditary apolipoprotein AI amyloidosis: endocrine involvement beyond hypogonadism.
    Pané A; Ruiz S; Orois A; Martínez D; Squarcia M; Sastre L; Ruiz P; Caballería J; Mora M; Hanzu FA; Halperin I
    Amyloid; 2018 Jun; 25(2):75-78. PubMed ID: 29446975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants.
    Del Giudice R; Arciello A; Itri F; Merlino A; Monti M; Buonanno M; Penco A; Canetti D; Petruk G; Monti SM; Relini A; Pucci P; Piccoli R; Monti DM
    Biochim Biophys Acta; 2016 Feb; 1860(2):434-44. PubMed ID: 26515634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre.
    Cohen OC; Blakeney IJ; Law S; Ravichandran S; Gilbertson J; Rowczenio D; Mahmood S; Sachchithanantham S; Wisniowski B; Lachmann HJ; Whelan CJ; Martinez-Naharro A; Fontana M; Hawkins PN; Gillmore JD; Wechalekar AD
    Amyloid; 2022 Dec; 29(4):237-244. PubMed ID: 35502644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel APOA1 gene mutations in a Japanese renal transplant recipient with recurrent apolipoprotein A-I related amyloidosis.
    Horike K; Takeda A; Tsujita M; Goto N; Watarai Y; Uchida K; Katayama A; Nishihira M; Shimizu A; Nozu K; Morozumi K
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():17-21. PubMed ID: 29968409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype.
    Tougaard BG; Pedersen KV; Krag SR; Gilbertson JA; Rowczenio D; Gillmore JD; Birn H
    Eur J Med Genet; 2016 Sep; 59(9):474-7. PubMed ID: 27240838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary apolipoprotein AI-associated renal amyloidosis: A diagnostic challenge.
    Samillán-Sosa Kdel R; Sención-Martínez G; Lopes-Martín V; Martínez-González MA; Solé M; Arostegui JL; Mesa J; García-Díaz Jde D; Rodríguez-Puyol D; Martínez-Miguel P
    Nefrologia; 2015; 35(3):322-7. PubMed ID: 26299174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis.
    Gregorini G; Izzi C; Obici L; Tardanico R; Röcken C; Viola BF; Capistrano M; Donadei S; Biasi L; Scalvini T; Merlini G; Scolari F
    J Am Soc Nephrol; 2005 Dec; 16(12):3680-6. PubMed ID: 16221867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal presentation of systemic apolipoprotein A-I-derived amyloidosis.
    Hazenberg AJ; Dikkers FG; Hawkins PN; Bijzet J; Rowczenio D; Gilbertson J; Posthumus MD; Leijsma MK; Hazenberg BP
    Laryngoscope; 2009 Mar; 119(3):608-15. PubMed ID: 19235761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary amyloidosis with progressive peripheral neuropathy associated with apolipoprotein AI Gly26Arg: outcome of hepatorenal transplantation.
    Testro AG; Brennan SO; Macdonell RA; Hawkins PN; Angus PW
    Liver Transpl; 2007 Jul; 13(7):1028-31. PubMed ID: 17600344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis.
    Colombat M; Aldigier JC; Rothschild PR; Javaugue V; Desport E; Frouget T; Goujon JM; Rioux-Leclercq N; Quellard N; Rerolle JP; Paraf F; Beugnet C; Tiple A; Durrbach A; Samuel D; Brézin A; Bridoux F; Valleix S
    Kidney Int; 2020 Jul; 98(1):195-208. PubMed ID: 32571483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis.
    Gregorini G; Izzi C; Ravani P; Obici L; Dallera N; Del Barba A; Negrinelli A; Tardanico R; Nardi M; Biasi L; Scalvini T; Merlini G; Scolari F
    Kidney Int; 2015 Jun; 87(6):1223-9. PubMed ID: 25565309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
    Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
    Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal Amyloidoses.
    Stangou AJ; Lobato L; Zeldenrust S; Rela M; Portmann B; Linke RP; Conceicao I; Otto G; Wilczek H; Suhr O; Azoulay D; Grateau G; Picken M; O'Grady J; Heaton N; Ericzon BG; Benson MD
    Amyloid; 2012 Jun; 19 Suppl 1():81-4. PubMed ID: 22540225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.
    Booth DR; Tan SY; Booth SE; Tennent GA; Hutchinson WL; Hsuan JJ; Totty NF; Truong O; Soutar AK; Hawkins PN; Bruguera M; Caballería J; Solé M; Campistol JM; Pepys MB
    J Clin Invest; 1996 Jun; 97(12):2714-21. PubMed ID: 8675681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
    Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
    FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland.
    Traynor CA; Tighe D; O'Brien FJ; Leavey SF; Dorman AM; Denton MD; Magee C; Conlon PJ
    Nephrology (Carlton); 2013 Aug; 18(8):549-54. PubMed ID: 23730806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.
    Rowczenio D; Dogan A; Theis JD; Vrana JA; Lachmann HJ; Wechalekar AD; Gilbertson JA; Hunt T; Gibbs SD; Sattianayagam PT; Pinney JH; Hawkins PN; Gillmore JD
    Am J Pathol; 2011 Oct; 179(4):1978-87. PubMed ID: 21820994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.